Life Sciences

China is striving to become the global leader in biopharmaceuticals, but many of its policy steps are “innovation mercantilist” in nature. This not only is expected to threaten U.S. leadership, but also slow global life sciences innovation, with negative consequences for cures and treatments.
Life Sciences
Check a box to narrow search for individual content items that cover numerous issues.
July 9, 2012
Based on ITIF’s reports, the unfortunate unemployment in life science and STEM fields has to do with inattention to public policies to keep the U.S. at the cutting edge of innovation.
May 17, 2012
The U.S. needs to re-examine its competitiveness in the life sciences sector.
May 17, 2012
Documents the role public investment plays in underpinning a nation’s competitiveness in the life sciences and competition for global life sciences leadership. NIH Director Francis S. Collins endorses this report in a recent New York Times interview.
November 2, 2011
Join us for an international forum discussing the future of health care innovation in times of financial crisis.
January 12, 2011
Rob Atkinson participated in a panel discussion examining how the U.S. can best foster investment in medical innovation.
November 11, 2010
Rob Atkinson presented at the PILMA Winter Meeting.
July 22, 2010
ITIF presents a conversation with Dr. Rob Epstein, the Chief Medical Officer of Medco to learn more about the latest innovations in healthcare technology.

Pages